AI brief of an SEC Form 8-K · FutureFuel Corp. (FF)

FutureFuel Q2 net income $11.4 million vs. $14.2 million loss a year earlier

Positive Impact 4 of 5 earnings Written later

FutureFuel reported second-quarter 2026 net income of $11.4 million, or $0.25 per diluted share, compared with a net loss of $14.2 million a year earlier, on revenue of $78.7 million, up 120.6%. Gross profit included a $9.1 million benefit from selling inventory above hedged prices and $3.2 million of unrealized derivative gains, and the company reiterated its expectation of positive full-year 2026 Adjusted EBITDA excluding derivative timing items. For shareholders, the quarter marked a return to profit, though the first half of 2026 still shows a net loss of $9.2 million.

Key points

  • Q2 2026 revenue of $78.7 million, up from $35.7 million in Q2 2025; Biofuel revenue rose to $52.9 million
  • Q2 2026 net income of $11.4 million ($0.25 per diluted share) vs. a net loss of $14.2 million in Q2 2025
  • Adjusted EBITDA of $11.8 million in Q2 2026 vs. a loss of $11.4 million a year earlier; first-half net loss of $9.2 million
  • Cash and equivalents of $34.4 million at June 30, 2026, up from $22.4 million at March 31, 2026; company expects $22 million in gross proceeds from tax credit monetization in the second half of 2026

The filing

CompanyFutureFuel Corp. (FF)
Form8-K, current report
Filed with the SECAug 10, 2026, 4:25 PM ET
Accession number0001437749-26-026783

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.